Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Hyperfine Inc (HYPR)

Hyperfine Inc (HYPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 128,325
  • Shares Outstanding, K 97,958
  • Annual Sales, $ 13,560 K
  • Annual Income, $ -35,570 K
  • EBIT $ -37 M
  • EBITDA $ -36 M
  • 60-Month Beta 1.06
  • Price/Sales 11.43
  • Price/Cash Flow N/A
  • Price/Book 3.15

Options Overview Details

View History
  • Implied Volatility 217.33% (-137.89%)
  • Historical Volatility 60.83%
  • IV Percentile 23%
  • IV Rank 11.22%
  • IV High 959.82% on 04/23/25
  • IV Low 123.51% on 08/26/25
  • Expected Move (DTE 24) 0.9945 (77.09%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 3
  • Volume Avg (30-Day) 32
  • Put/Call OI Ratio 0.02
  • Today's Open Interest 1,292
  • Open Int (30-Day) 2,720
  • Expected Range 0.2955 to 2.2845

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.09
  • Number of Estimates 1
  • High Estimate $-0.09
  • Low Estimate $-0.09
  • Prior Year $-0.12
  • Growth Rate Est. (year over year) +25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0300 +25.24%
on 03/30/26
1.4000 -7.86%
on 04/16/26
+0.0500 (+4.03%)
since 03/20/26
3-Month
1.0150 +27.09%
on 03/02/26
1.4000 -7.86%
on 04/16/26
+0.0900 (+7.50%)
since 01/20/26
52-Week
0.5327 +142.16%
on 05/23/25
2.2200 -41.89%
on 10/15/25
+0.5939 (+85.32%)
since 04/17/25

Most Recent Stories

More News
Hyperfine Receives CE and UKCA Marks for Next-Generation Swoop® System and Latest Advancement in Optive AI™ Software

This milestone unlocks Hyperfine’s most significant technology innovations to date for clinicians and patients across Europe and the United Kingdom, delivering a transformative leap in image quality...

HYPR : 1.2900 (-1.53%)
Horizon Technology Finance Provides $40 Million Loan Facility to Hyperfine

Horizon Technology Finance Corporation (NASDAQ: HRZN) (“Horizon”) (the “Company”), an affiliate of Monroe Capital, today announced it has provided a $40 million loan facility to Hyperfine, Inc....

HYPR : 1.2900 (-1.53%)
HRZN : 4.29 (-2.05%)
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the...

HYPR : 1.2900 (-1.53%)
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop®...

HYPR : 1.2900 (-1.53%)
Hyperfine Announces Publication of Breakthrough Clinical Data Demonstrating the Swoop® System’s Enhanced Stroke Detection Capabilities

The largest dataset to date on stroke detection with the Swoop® system demonstrates the ability to identify small strokes rapidly and reliably, reinforcing its clinical value for acute care and emergency...

HYPR : 1.2900 (-1.53%)
Hyperfine Announces NEURO PMR Study Results Showing High Diagnostic Value and Superior Patient Experience in Neurology Clinics

Data presented at the annual American Society of Neuroimaging meeting supports clinical value and broad utility of the portable Swoop® system in outpatient neurology.

HYPR : 1.2900 (-1.53%)
Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop® System with Contrast Agents

The prospective study is designed to evaluate the feasibility and visualization benefits of contrast-enhanced ultra-low-field portable MRI to support an FDA 510(k) submission.

HYPR : 1.2900 (-1.53%)
Hyperfine Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results

Hyperfine Delivers Quarterly Record Revenue of Approximately $5.3 Million in Q4 2025, Representing Transformative Growth of 54% Compared to Prior Quarter; Exiting 2025 with Approximately $35 Million of...

HYPR : 1.2900 (-1.53%)
Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced...

HYPR : 1.2900 (-1.53%)
OFIX : 12.65 (-0.47%)
SPNC : 38.45 (unch)
AVNS : 24.64 (+0.08%)
PLSE : 23.73 (+1.41%)
SWAV : 334.75 (-0.02%)
Hyperfine Announces First Peer-Reviewed Publication Demonstrating Significant Economic Benefits of Using the Swoop® AI-Powered Portable MRI System in Acute Hospital Care

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today...

HYPR : 1.2900 (-1.53%)

Business Summary

Hyperfine Inc. is a groundbreaking medical device company which created Swoop(R), first FDA-cleared portable MRI system(TM). Hyperfine Inc., formerly known as HealthCor Catalio Acquisition Corp., is based in GUILFORD, Conn.

See More

Key Turning Points

3rd Resistance Point 1.3867
2nd Resistance Point 1.3633
1st Resistance Point 1.3267
Last Price 1.2900
1st Support Level 1.2667
2nd Support Level 1.2433
3rd Support Level 1.2067

See More

52-Week High 2.2200
Fibonacci 61.8% 1.5755
Fibonacci 50% 1.3764
Last Price 1.2900
Fibonacci 38.2% 1.1772
52-Week Low 0.5327

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.